• Pneumonia and lower respiratory tract infections

• Urinary tract infections (UTIs)

• Sepsis or bloodstream infections

• Meningitis

• Surgical wound infections

• Infections caused by multidrug-resistant Acinetobacter species

Kiviza 1gm Injection works by blocking the action of an enzyme called beta-lactamase, which is produced by certain bacteria to resist antibiotics. By inhibiting this enzyme, Kiviza helps antibiotics work better and allows them to kill the bacteria more effectively. It also has direct antibacterial action against certain strains like Acinetobacter baumannii, Bacteroides fragilis, Neisseria gonorrhoeae, and Neisseria meningitidis.

Avoid using Kiviza with the following medicines without medical advice:

Always inform your doctor about all prescription, OTC, and herbal medicines you are taking before starting Kiviza.

• Store at 20°C to 25°C.

• Protect from light, heat, and moisture.

• Keep out of reach of children and pets.

Kiviza 1gm Injection is given by a doctor or nurse in a hospital or clinic setting. The dose, frequency, and duration will depend on your condition and how your body responds to the treatment. Never skip doses and complete the full course even if you start feeling better.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. 

Serious:

• Severe allergic reactions (rashes, itching, difficulty in breathing, fever)

Common:

• Injection site pain (which is usually minimized by diluting with local anesthesia by the physician)
• Thrombophlebitis (inflammation of the vein)
• Diarrhoea

• Kiviza 1gm Injection is used with antibiotics to treat serious bacterial infections.

• It may be given alone to treat infections caused by Acinetobacter baumannii.

• Common side effects include injection site pain and diarrhea.

• Do not stop the medication midway unless advised by your doctor.

• Always inform your doctor if you are pregnant, breastfeeding, or have allergies to penicillin or related antibiotics.

1. Ciplamed, Food and Drug Administration (FDA),[Revised on Sep 2014] [Accessed on Sep 2023]https://ciplamed-library.com/content/sulbacip-iv-injection 

2. Pfizer, Food and Drug Safety Administration (FDA), [Revised on Jan 2012] [Aaccessed on Sep2023]https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050608s040lbl.pdf

3. La Jolla Pharmaceutical Company, Waltham, Food and Drug Safety Administration (FDA) [Revised May 2023][Accessed on Sep 2023]https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216974Orig1s000Correctedlbl.pdf 

4.La Renon Healthcare; [Accessed on Sep 2023]http://www.larenon.com/wp-content/uploads/2015/08/kiviza_one_page_lbl.pdf

5. Basil V. P. et al., Ampicillin/Sulbactam, published Oct 2022,[Accessed on sep2023]https://www.ncbi.nlm.nih.gov/books/NBK526117/

6. KD Tripathi, Essentials of Medical Pharmacology, Beta-lactam antibiotics, 7th edition, 2013, 725.

7. Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Penicillins, cephalosporins, and other beta-lactam antibiotics, 12th edition, 2011, 1501.